CSIMarket
 


Retractable Technologies inc   (RVP)
Other Ticker:  
 
 

RVP's Capital Expenditures Growth by Quarter and Year

Retractable Technologies Inc 's Capital Expenditures results by quarter and year




RVP Capital Expenditures (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 3.34 25.54 0.19
III Quarter September 0.14 5.57 12.61 0.19
II Quarter June 0.09 4.97 11.57 0.14
I Quarter March 0.47 8.36 9.10 0.14
FY   0.70 22.24 58.82 0.66



RVP Capital Expenditures third quarter 2023 Y/Y Growth Comment
Retractable Technologies Inc reported drop in Capital Expenditures in the third quarter 2023 by -97.43% to $ 0.14 millions, from the same quarter in 2022.
The fall in the third quarter 2023 Retractable Technologies Inc 's Capital Expenditures compares unfavorably to the Company's average Capital Expenditures doubling of 583.1%.

Looking into third quarter 2023 results within Medical Equipment & Supplies industry 72 other companies have achieved higher Capital Expenditures growth. While Retractable Technologies Inc ' s Capital Expenditures meltdown of -97.43% ranks overall at the positon no. 1604 in the third quarter 2023.




RVP Capital Expenditures ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -86.92 % 13342.11 % -40.63 %
III Quarter September -97.43 % -55.83 % 6536.84 % 533.33 %
II Quarter June -98.19 % -57.04 % 8164.29 % 55.56 %
I Quarter March -94.38 % -8.13 % 6400 % -6.67 %
FY   - -62.19 % 8812.12 % 11.86 %

Financial Statements
Retractable Technologies Inc 's third quarter 2023 Capital Expenditures $ 0.14 millions RVP's Income Statement
Retractable Technologies Inc 's third quarter 2022 Capital Expenditures $ 5.57 millions Quarterly RVP's Income Statement
New: More RVP's historic Capital Expenditures Growth >>


RVP Capital Expenditures (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -40.04 % 102.54 % 0 %
III Quarter September 58.78 % 12.07 % 8.99 % 35.71 %
II Quarter June -80.85 % -40.55 % 27.14 % 0 %
I Quarter March -85.93 % -67.27 % 4689.47 % -56.25 %
FY (Year on Year)   - -62.19 % 8812.12 % 11.86 %




Capital Expenditures third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #73
Healthcare Sector #230
Overall #1604

Capital Expenditures Y/Y Growth Statistics
High Average Low
8807.45 % 583.1 % -95.28 %
(Jun 30 2021)   (Dec 31 2017)
Capital Expenditures third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #73
Healthcare Sector #230
Overall #1604
Capital Expenditures Y/Y Growth Statistics
High Average Low
8807.45 % 583.1 % -95.28 %
(Jun 30 2021)   (Dec 31 2017)

Capital Expenditures by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Retractable Technologies Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
4740.06 % 222.28 % -100 %
(Sep 30 2020)  


RVP's III. Quarter Q/Q Capital Expenditures Comment
Retractable Technologies inc achieved in the III. Quarter 2023 below company average Capital Expenditures jump of 58.78% quarter on quarter, to $ 0.14 millions.

Even if the III. Quarter 2023 RVP's Capital Expenditures Q/Q growth was below the regular , it has been yet promising sign, as the III. Quarter expension, eclipses the 12.07% surge in the III. Quarter 2022

Within Medical Equipment & Supplies industry 30 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Retractable Technologies Inc 's Capital Expenditures growth quarter on quarter, overall rank is 573.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #31
Healthcare Sector #129
Overall #573
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #31
Healthcare Sector #129
Overall #573
Capital Expenditures Q/Q Growth Statistics
High Average Low
4740.06 % 222.28 % -100 %
(Sep 30 2020)  


RVP's III. Quarter Q/Q Capital Expenditures Comment
Retractable Technologies inc achieved in the III. Quarter 2023 below company average Capital Expenditures jump of 58.78% quarter on quarter, to $ 0.14 millions.

Although the III. Quarter 2023 RVP's Capital Expenditures quarter on quarter growth was beneath the regular of 222.28 %, this was yet promising news, as the III. Quarter surge, outshines the 12.07% growth in the III. Quarter 2022

Within Medical Equipment & Supplies industry 30 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Retractable Technologies Inc 's Capital Expenditures growth quarter on quarter, overall rank is 573.


Retractable Technologies Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Capital Expenditures 12 Months Ending $ 4.04 $ 9.47 $ 14.35 $ 22.24 $ 44.44
Y / Y Capital Expenditures Growth (TTM) -90.91 % -81.61 % -75.3 % -62.19 % 32.76 %
Year on Year Capital Expenditures Growth Overall Ranking # 738 # 191 # 6 # 0 # 0
Seqeuential Capital Expenditures Change (TTM) -57.34 % -34.01 % -35.49 % -49.95 % -13.67 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1680 # 1551 # 538 # 0 # 0




Cumulative Capital Expenditures growth Comment
Retractable Technologies Inc 's cumulative 12 months Capital Expenditures continue to drop, but on the faster rate at -90.91% year on year, at Sep 30 2023 compare to the -81.61% decrease at Jun 30 2023. If the Retractable Technologies Inc 's fiscal year would end at Sep 30 2023, annual Capital Expenditures would be $4 millions.

In the Healthcare sector 104 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 191 to 738.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
8807.45 %
583.1 %
-95.28 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 76
Healthcare Sector # 105
Overall # 738

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
8807.45 %
583.1 %
-95.28 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 76
Sector # 237
S&P 500 # 1680
Cumulative Capital Expenditures growth Comment
Retractable Technologies Inc 's cumulative 12 months Capital Expenditures continue to drop, but on the faster rate at -90.91% year on year, at Sep 30 2023 compare to the -81.61% decrease at Jun 30 2023. If the Retractable Technologies Inc 's fiscal year would end at Sep 30 2023, annual Capital Expenditures would be $4 millions.

In the Healthcare sector 104 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 191 to 738.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
8807.45 %
583.1 %
-95.28 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 76
Healthcare Sector # 105
Overall # 738

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
8807.45 %
583.1 %
-95.28 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 76
Sector # 237
S&P 500 # 1680




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
RVP's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for RVP's Competitors
Capital Expenditures Growth for Retractable Technologies Inc 's Suppliers
Capital Expenditures Growth for RVP's Customers

You may also want to know
RVP's Annual Growth Rates RVP's Profitability Ratios RVP's Asset Turnover Ratio RVP's Dividend Growth
RVP's Roe RVP's Valuation Ratios RVP's Financial Strength Ratios RVP's Dividend Payout Ratio
RVP's Roa RVP's Inventory Turnover Ratio RVP's Growth Rates RVP's Dividend Comparisons



Companies with similar Capital Expenditures drop for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Sep 30 2023
Encompass Health Corporation-0.54%$ -0.542 millions
Myriad Genetics Inc -1.13%$ -1.130 millions
Opgen inc -1.22%$ -1.220 millions
Avantor Inc -3.33%$ -3.333 millions
United Therapeutics Corporation-4.51%$ -4.506 millions
Enanta Pharmaceuticals Inc-4.80%$ -4.802 millions
Davita Inc -5.46%$ -5.463 millions
Science 37 Holdings Inc -5.63%$ -5.630 millions
Cutera Inc -5.71%$ -5.708 millions
Zoetis Inc -5.84%$ -5.844 millions
U S Physical Therapy Inc-6.25%$ -6.248 millions
Generation Bio Co -6.30%$ -6.298 millions
Ngm Biopharmaceuticals Inc -6.45%$ -6.452 millions
Becton Dickinson And Company-6.67%$ -6.667 millions
3m Company-6.90%$ -6.897 millions
Apyx Medical Corporation-7.45%$ -7.447 millions
Edwards Lifesciences Corporation-7.68%$ -7.679 millions
Viatris Inc -7.70%$ -7.700 millions
Luna Innovations Inc-8.23%$ -8.232 millions
Nevro Corp -8.38%$ -8.377 millions
Shockwave Medical Inc -8.65%$ -8.649 millions
Sonendo Inc -8.86%$ -8.861 millions
Charles River Laboratories International inc -8.90%$ -8.904 millions
Nautilus Biotechnology Inc -9.24%$ -9.242 millions
Harvard Bioscience Inc-9.28%$ -9.276 millions
Fulgent Genetics Inc -9.42%$ -9.420 millions
Idexx Laboratories Inc-9.53%$ -9.529 millions
Sage Therapeutics Inc -9.89%$ -9.890 millions
Caredx Inc -10.40%$ -10.400 millions
Quest Diagnostics Inc-11.02%$ -11.017 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com